We implemented hospital information system (HIS) alerts to deter unnecessary test orders for ovum and parasite (O&P) exams and Clostridium difficile PCR. The HIS alerts decreased noncompliant O&P orders (orders after >72 h of hospitalization) from 49.8% to 30.9%, an overall decrease of 19%, and reduced noncompliant C. difficile PCR orders (orders <7 days after a previous positive result) from 30.6% to 19.2%, an overall decrease of 31.9%.
I
mmunocompromised patients frequently present with acute diarrhea due to an unknown etiology. In this patient population, diarrhea may be related to chemotherapy, graft-versus-host disease, antibiotics, other medications, (e.g., laxatives), or infectious disease agents; thus, clinically distinguishing between these causes can be difficult (1) . Furthermore, these patients are at a higher risk for complications from infectious causes of gastroenteritis (2) , highlighting the importance of correct and timely laboratory testing (1) . On the other hand, unnecessary and duplicate testing can result in additional expenses, laboratory workloads, and burdens on patients and related hospital staff (3, 4) .
Clostridium difficile infection (CDI) is one of the most common hospital-acquired infections and is an increasingly frequent cause of morbidity and mortality in hospitalized patients (5) . CDI can lead to colitis, toxic megacolon, and even death (6); it is linked to more than a half million infections and 14,000 deaths each year in the United States (7) . PCR testing has become the test of choice for the diagnosis of CDI; however, numerous studies have demonstrated that repeat C. difficile PCR testing, especially within the first 7 days of an initial positive test, does not change the test result in 97% to 99% of patients. Furthermore, repeat testing within 48 h of a negative result changed the result in only 1.9% of patients (8) . In both cases, overordering these tests has been shown to lead to increased hospital costs and potential false-positive results (3, 4, 9) .
Gastroenteritis can also be caused by a number of parasitic pathogens, including Giardia lamblia and Cryptosporidium species. Ovum and parasite (O&P) exams are an effective tool for identifying infections caused by these organisms; however, the utility of the O&P exam in patients with long-term hospital stays has been called into question. A number of studies have shown that the differential diagnoses for infectious causes of hospitalacquired versus community-acquired infections have great differences. For example, for community-acquired diarrhea, it is reasonable to consider parasitic infections or bacterial infections from organisms such as Salmonella, Shigella, or Campylobacter; these organisms have rarely been shown to cause hospital-acquired infections except in rare outbreaks of food poisoning (10, 11) . Seigel et al. evaluated the positivity rates of O&P examinations in patients with fewer than 3 days of hospitalization compared to those with greater than 3 days of hospitalization (12) . In this study, none of the samples submitted from patients with greater than 3 days of hospitalization were positive, demonstrating that there is no utility to testing for O&P in patients whose hospital stay is longer than 3 days (13). Another study by Kamboj et al. (14) demonstrated little utility of the O&P exam in early (day Ϫ10 to day 30) or late (day 31 to day 90) post-hematopoietic stem cell transplant periods. The authors suggested that testing for O&P in this population is futile unless there is clinical or epidemiological data suggesting parasitic infection, such as the presence of Strongyloides (14) . Furthermore, testing for O&P after 3 days of hospitalization is not recommended by the Infectious Diseases Society of America (IDSA) or the American Society for Microbiology (ASM) (15) . Therefore, the relatively time-consuming O&P exam should only be reserved for outpatients, those who are admitted to the hospital for a diarrheal illness caused by a community-acquired infection, or immunocompromised patients with suspicion of Strongyloides infection regardless of admission length (12, 16) .
(This study was presented in part at the Association for Molecular Pathology Annual Meeting, National Harbor, MD, 12 to 15 November 2014.)
Our institution is a specialized cancer center in which many patients are hospitalized for long periods of time and have idiopathic diarrhea. To test for possible parasitic infections, our laboratory provides a full O&P analysis with trichrome staining. In September 2010, the clinical microbiology laboratory implemented the Cepheid Xpert C. difficile assay (Cepheid, Sunnyvale, CA) (17) . With the change in testing methodology combined with the long hospital stays of this population, we observed increased unnecessary orders for C. difficile PCR. As a cost-savings and quality-improvement project, we implemented four alerts in the hospital information system (HIS) with the overall goal to decrease unnecessary and duplicate ordering for C. difficile PCR and O&P exams (Fig. 1) . The alerts were deployed on May 13, 2013, and were as follows: (1) C. difficile testing is not recommended within 7 days after a positive result (2); C. difficile testing is not recommended within 48 h of a previous negative test (3); testing stool in an O&P exam is not recommended for patients who have been hospitalized for more than 72 h (4); and infectious disease consultation approval is required for these orders. The appropriate alert appeared in the HIS test ordering window when a patient had either a negative C. difficile result within the last 48 h or a positive result within the last 7 days, or when ordering an O&P exam if the patient had been admitted to the hospital for greater than 72 h. Finally, if the physician moved forward with ordering a noncompliant test, an additional message was displayed with instructions to obtain approval from an infectious disease physician if the user believed that testing was necessary. The ordering physician was then required to enter the name of the person who approved the order before proceeding. In this study, we measured the impact of the alerts by reviewing and analyzing the overall test volumes and the rates of compliance with test orders for 12 months before and 12 months after implementation of these alerts. Overall, the O&P ordering volume decreased after implementing the order alerts. The average (Ϯ standard deviation) monthly inpatient O&P orders decreased from 89.9 Ϯ 21.5 per month to 33.5 Ϯ 6.3 per month (a 63% decrease) before and after, respectively, the May 13, 2013, go-live date. The average (Ϯ standard deviation) monthly number of noncompliant O&P orders, or those placed after 72 h of a patient being hospitalized, was reduced from 47 Ϯ 13 (33.5%) to 10 Ϯ 5 (12.9%), an overall decrease of 58.7% (P ϭ 0.0000). There was a corresponding increase in compliant samples from 49% compliant to 72% compliant ( Fig. 2A) . Furthermore, the average (Ϯ standard deviation) rate of positive O&P exams was significantly increased from 1.5% Ϯ 0.02% to 3.8% Ϯ 0.04% (P ϭ 0.0488) following implementation of the order alerts ( Fig. 2A) . It is important to note that all of the noncompliant tests completed after implementing the order alerts were negative.
In the year following the alerts implementation, the overall average (Ϯ standard deviation) volume of monthly C. difficile orders increased from 401.9 Ϯ 155.98 to 476.69 Ϯ 46.9 orders per month (an 18.6% increase). Despite the increase in test order volume, the overall number of noncompliant orders decreased from 4.0% to 2.6% (P ϭ 0.039). Prior to the order alerts, only 2 of 2,273 (0.09%) orders were requested within 48 h of a negative result; however, after we implemented the order alerts, there were 0 of 3,743 (0%) sample tests ordered within 48 h of a negative result. With respect to the noncompliant orders following a previous positive result, an average of 30.6% of samples (104 of 340 samples) were noncompliant each month prior to alert implementation, meaning that a second C. difficile order was requested within 7 days of a previous positive sample. However, after implementing the order alerts, the average monthly rate of noncompliant sample orders was reduced to 19.2% (81 of 422 sample orders), an overall decrease of 31.9% (P ϭ 0.028). Figure 2B summarizes the overall changes in sample volume and the number of compliant samples before and after implementing the alerts.
Unnecessary laboratory orders impose significant financial and workload burdens onto clinical laboratories (3, 4) . Some laboratories have taken different strategies to decrease unnecessary C. difficile testing by, for example, only accepting liquid stool samples for processing (15) . However, previous studies have shown that computerized prompts are an important way of modifying physician behaviors. A systematic review of the literature by Schedlbauer et al. showed that 23 of 27 papers demonstrated benefit in improving prescribing behavior and/or reducing error rates by implementing computerized order alerts (18) . Luo et al. (19) implemented a policy at their institution to reject repeat PCR testing for CDI within 7 days of an initial test except with the approval of the microbiology laboratory director. This group used a series of pop-up windows in the HIS ordering system that were triggered when a physician attempted to order a C. difficile PCR test within 7 days of a previous positive result. While this approach was shown to be an effective way to reduce duplicate ordering, a limitation of order alerts is that physicians often suffer from alert fatigue, whereby excessive warnings may cause them to pay less attention to vital alerts, thus limiting the effectiveness of these systems (20) . In the system we applied here, the ordering physicians were unable to continue with a noncompliant order without consulting with an infectious disease physician. This strategy helped improve the efficacy of the alerts, but it still allowed order-ing if it was clinically indicated. A cost analysis by Nistico et al. showed that the cost savings of reducing unnecessary C. difficile testing extends from the laboratory to other areas of the hospital costs, such as vancomycin usage, hospital isolation days, and other hospital-wide costs (4, 19) . Here, we show that computerized alerts in the hospital order management system significantly reduced noncompliant C. difficile and O&P orders. The alerts in the hospital HIS reduced the noncompliant O&P exam orders by 58.7%. In addition, the order alerts reduced noncompliant C. difficile orders by 31.9% and 0.09% for repeat testing following a positive and a negative result, respectively. The repeat C. difficile testing following a negative test was not a problem prior to implementing the order alerts and, therefore, showed a minimal decrease in noncompliance. In conclusion, HIS order alerts are an effective approach to minimizing unnecessary and duplicate ordering of C. difficile and O&P exams in the hospital setting.
